Independent analysis puts a CPC tirzepatide lot at 96.6%, against 92.7% on the certificate
A reminder that a purity figure is the output of a method, and that methods differ.
April 2025 — Vol. 2, No. 4
Page 4 of 4 of this archive, newest first.
Also filed — page 4
the rolling newsroom, April 2025SURPASS-3 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Saudi Arabia health authority warns on falsified dulaglutide pens
Reported from the analysis, not from a warning notice.
From the floor in Qingdao: 3 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What a 27% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
Singapore caps dulaglutide prescribing to 15 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The quiet end of Calder Vale Peptides of Skipton
A proper account of an operation that existed, and of what closing it cost.
A shortage listing ends. 9 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
Ireland pharmacy body issues counselling standards for liraglutide initiation
The evidence base is thin and the document says so, which is to its credit.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The online reseller trading as Adamant Research Supply closes after 19 years
A proper account of an operation that existed, and of what closing it cost.
The 28-day notice: how a compounding wind-down works in Germany
The document is four pages. Three of them are about dates.
What the new Singapore guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Nantong: 15 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Medutest result on a Tianjin semaglutide lot lands 2.4 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
What changed at JEEP in April, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The Netherlands pharmacy body issues counselling standards for tirzepatide initiation
The evidence base is thin and the document says so, which is to its credit.
The relabeller trading as Vantris Bio enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
The Netherlands health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
Hangzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.